Our mission is to empower those entrepreneurs and scientific teams to create value and transform our approach to health care. It’s time to change the world.
Pharma / Biotech / Digital Health / Med Tech
Seed to Later Stage
DACH / German-speaking Europe
Investment team with strong clinical, scientific and entrepreneurial backgrounds
International and highly experienced network
Valued at some $430B in 2019
Generic pharmaceuticals market was valued at about $217B in 2018 and is expected to grow to around $309B at an annual growth rate of more than 9% through 2022
Global pharmaceutical industry will be worth $1.6 trillion with a CAGR of 6%
Oncology as the no. 1 therapy will reach $233B with 12.2% CAGR. Prescription drug sales between 2019 and 2024 are projected to have a positive CAGR of 6.9% with sales expected to reach $1.18 trillion.
Biotechnology market size surpassed $417B in 2018 and is projected to achieve a value of $755B in 2025 at 8.3% CAGR
Digital health forecasted $500B annual sales until 2026 with 20% CAGR
Homepage Health Hub Tirol
Welcome to Standortagentur Tirol
Standortagentur Tirol offers professional support and advice to help you on your road to success.Innovation, growth, location development and marketing: Standortagentur Tirol has a comprehensive range of services to assist your company or research institute with your growth or start-up projects in Tyrol and will support you in establishing regional, national and international networks. Standortagentur Tirol develops joint projects with you based on the Tyrolean skills triangle of technology, health and tourism, balancing economical and ecological, social and cultural as well as regional and global issues. Our common goal: achieving market leadership, increasing competitiveness, safeguarding existing jobs, and creating new long-term jobs.
We look forward to meeting you and supporting you with your projects.
Homepage Standortagentur Tirol
Our team has an impressive track record in industry knowledge, competition & regulatory environment, and high-level skills in financing, restructuring, growing and performance improving.
30 years of experience in the pharmaceutical & biotech industries (BMS, Takeda, Pharmacia, etc.)
15+ years of professional investment experience, a venture capital expert, M&A deal-maker, serial entrepreneur and angel investor
VENIONAIRE CAPITAL GES.M.B.H.
VIENNA, OFFICE (HQ)Babenbergerstraße 9/12,A-1010 Vienna, Austria (EU)firstname.lastname@example.org
CB one Holding GmbH
Geweygasse 5, Top 2A-1190 Viennainfo@cb-one-holding.comwww.cb-one-holding.com
LSF2030 GmbH & Co KG
Kaiserjägerstraße 16020 InnsbruckÖsterreich
The Sustainable Development Goals are a universal call to action to end poverty, protect the planet and improve the lives and prospects of everyone, everywhere.
WE BELIEVE IN PEOPLE WITH IDEAS FOR THE FUTURE OF HEALTH.
LifeSciences2030 fund supports goal 3 “Good Health and Wellbeing For All” of the Sustainable Development Goals! We are looking for investors, founders and startups who want to improve healthcare with new solutions for a healthier world.